Clinical Trial Update: Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer

View source ↗

Summary

The entry reports a real-world clinical trial evaluating the Endopredict prognostic test in early HR-positive, HER2-negative breast cancer; the study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer

Drugs mentioned

• Endopredict

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Breast Cancer (Early Breast Cancer), Breast Cancer Survivors | Status: RECRUITING